4

OWNERSHIP DOCUMENT

Company: Matinas BioPharma Holdings, Inc.
Filed: February 13, 2019
Period of Report: February 11, 2019
Accession Number: 0000905718-19-000110

View Document ↗ View on SEC.gov ↗